Epic Bio, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine with Epigenetic Engineering

– $55 million Series A financing will advance the company‚Äôs robust preclinical pipeline and ongoing discovery efforts –  – Epic holds exclusive license to smallest known Cas protein, enabling in vivo delivery via AAV vector to wide range of target organs – –  Lead program in facioscapulohumeral muscular dystrophy (FSHD) on track for clinical initiation … Read more